Zealand vet Hansen latest add to Augustine’s C-suite

Augustine Therapeutics B.V. is continuing to build its C-suite in the wake of its €78 million ($85 million) series A round, announced in March. Its latest hire, CSO Rie Schultz Hansen, arrives from Aelin Therapeutics B.V., where she was CSO; she also spent nearly 12 years at Zealand Pharma A/S (NASDAQ:ZEAL). Augustine, focused on HDAC6-targeting therapies, hired a CFO and a CBO in late April. With Hansen’s arrival, the company has also created a subsidiary in Copenhagen focused on cardiometabolic therapies.

Cancer detection company Freenome Inc. named Linh Le as its new CFO. He was CFO of Predicine Inc. The start-up has raised more than $1.3 billion in private funding since 2016...